Search by Drug Name or NDC
NDC 00603-0213-21 Magnesium Oxide 253 mg/1 Details
Magnesium Oxide 253 mg/1
Magnesium Oxide is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by PAR Pharmaceuticals. The primary component is MAGNESIUM OXIDE.
MedlinePlus Drug Summary
Magnesium is an element your body needs to function normally. Magnesium oxide may be used for different reasons. Some people use it as an antacid to relieve heartburn, sour stomach, or acid indigestion. Magnesium oxide also may be used as a laxative for short-term, rapid emptying of the bowel (before surgery, for example). It should not be used repeatedly. Magnesium oxide also is used as a dietary supplement when the amount of magnesium in the diet is not enough. Magnesium oxide is available without a prescription.
Related Packages: 00603-0213-21Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Magnesium Oxide
Product Information
| NDC | 00603-0213 |
|---|---|
| Product ID | 0603-0213_b40d866b-76d8-4522-bf1b-0ad137cedb42 |
| Associated GPIs | 48400020000315 |
| GCN Sequence Number | 001409 |
| GCN Sequence Number Description | magnesium oxide TABLET 420 MG ORAL |
| HIC3 | C1H |
| HIC3 Description | MAGNESIUM SALTS REPLACEMENT |
| GCN | 04093 |
| HICL Sequence Number | 000609 |
| HICL Sequence Number Description | MAGNESIUM OXIDE |
| Brand/Generic | Generic |
| Proprietary Name | Magnesium Oxide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Magnesium Oxide |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 253 |
| Active Ingredient Units | mg/1 |
| Substance Name | MAGNESIUM OXIDE |
| Labeler Name | PAR Pharmaceuticals |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M001 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00603-0213-21 (00603021321)
| NDC Package Code | 0603-0213-21 |
|---|---|
| Billing NDC | 00603021321 |
| Package | 100 TABLET in 1 BOTTLE (0603-0213-21) |
| Marketing Start Date | 2020-11-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |